FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/09/2022 |
3. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 14,799.549(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (2) | 07/30/2029 | Common Stock | 10,300 | 4.53 | D | |
Employee Stock Option (right to buy) | (3) | 04/28/2030 | Common Stock | 5,140 | 3.2 | D | |
Employee Stock Option (right to buy) | (4) | 04/27/2031 | Common Stock | 10,000 | 13.13 | D |
Explanation of Responses: |
1. Includes shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. Also consists of (1) 3,400, 1,700 and 3,500 shares granted pursuant to the Issuer's Amended and Restated 2014 Stock Plan (the "Stock Plan") on July 31, 2019, April 29, 2020 and April 28, 2021, respectively, each of which vest 25% annually commencing on the first anniversary of the grant date; and (2) 6,000 shares granted pursuant to the Stock Plan which vest on March 10, 2024 dependent on certain performance criteria. The maximum number of shares that may vest pursuant to the performance criteria is 9,000. |
2. Stock option granted on July 31, 2019 pursuant to the Stock Plan and will vest 25% annually commencing on July 31, 2020. |
3. Stock option granted on April 29, 2020 pursuant to the Stock Plan and will vest 25% annually commencing on April 29, 2021. |
4. Stock option granted on April 28, 2021 pursuant to the Stock Plan and will vest 25% annually commencing on April 28, 2022. |
/s/ Scott Eric Nolen | 03/25/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |